Machine Learning Models to Predict 24 Hour Urinary Abnormalities for Kidney Stone Disease.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
11 2022
Historique:
received: 12 04 2022
revised: 21 06 2022
accepted: 04 07 2022
pubmed: 20 7 2022
medline: 16 11 2022
entrez: 19 7 2022
Statut: ppublish

Résumé

To help guide empiric therapy for kidney stone disease, we sought to demonstrate the feasibility of predicting 24-hour urine abnormalities using machine learning methods. We trained a machine learning model (XGBoost [XG]) to predict 24-hour urine abnormalities from electronic health record-derived data (n = 1314). The machine learning model was compared to a logistic regression model [LR]. Additionally, an ensemble (EN) model combining both XG and LR models was evaluated as well. Models predicted binary 24-hour urine values for volume, sodium, oxalate, calcium, uric acid, and citrate; as well as a multiclass prediction of pH. We evaluated performance using area under the receiver operating curve (AUC-ROC) and identified predictors for each model. The XG model was able to discriminate 24-hour urine abnormalities with fair performance, comparable to LR. The XG model most accurately predicted abnormalities of urine volume (accuracy = 98%, AUC-ROC = 0.59), uric acid (69%, 0.73) and elevated urine sodium (71%, 0.79). The LR model outperformed the XG model alone in prediction of abnormalities of urinary pH (AUC-ROC of 0.66 vs 0.57) and citrate (0.69 vs 0.64). The EN model most accurately predicted abnormalities of oxalate (accuracy = 65%, ROC-AUC = 0.70) and citrate (65%, 0.69) with overall similar predictive performance to either XG or LR alone. Body mass index, age, and gender were the three most important features for training the models for all outcomes. Urine chemistry prediction for kidney stone disease appears to be feasible with machine learning methods. Further optimization of the performance could facilitate dietary or pharmacologic prevention.

Identifiants

pubmed: 35853510
pii: S0090-4295(22)00598-2
doi: 10.1016/j.urology.2022.07.008
pii:
doi:

Substances chimiques

Uric Acid 268B43MJ25
Oxalates 0
Citrates 0
Sodium 9NEZ333N27
Citric Acid 2968PHW8QP

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

52-57

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR000445
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Nicholas L Kavoussi (NL)

Department of Urology, Vanderbilt University Medical Center, Nashville, TN. Electronic address: Nicholas.l.kavoussi@vumc.org.

Chase Floyd (C)

University of South Carolina School of Medicine, Columbia, SC.

Abin Abraham (A)

Department of Biological Sciences, Vanderbilt Genetics Institute, and Center for Structural Biology, Vanderbilt University, Nashville, TN.

Wilson Sui (W)

Department of Urology, Vanderbilt University Medical Center, Nashville, TN.

Cosmin Bejan (C)

Department of Biological Sciences, Vanderbilt Genetics Institute, and Center for Structural Biology, Vanderbilt University, Nashville, TN.

John A Capra (JA)

Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN; Bakar Computational Health Sciences Institute at the University of California, San Francisco, CA; Department of Epidemiology and Biostatistics at the University of California, San Francisco, CA.

Ryan Hsi (R)

Department of Urology, Vanderbilt University Medical Center, Nashville, TN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH